Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Minerva Chirurgica
|
November 1, 1996
[Cancerous colonic polyps]
R Manetti, M Biagini, G Giustarini
Journal of Experimental & Clinical Cancer Research : CR
|
June 14, 2006
Low-dose thalidomide plus monthly high-dose oral dexamethasone (Thali-Dexa): results, prognostic factors and side effects in eight patients previously treated with multiple myeloma
P Bemardeschi, P Dentico, S Rossi, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 14, 2006
Thyroid metastases from colon cancer case report in a long term survivor
S Rossi, G Fiorentini, G Porcu, et al.
Journal of Chemotherapy (Florence, Italy)
|
January 29, 2005
Chemoresistant myeloma: phase II clinical study with low-dose thalidomide plus high-dose dexamethasone
P Bernardeschi, P Dentico, S Rossi, et al.
European Journal of Haematology
|
November 1, 1987
Single-dose pharmacokinetics of factor IX evaluated by model-independent methods
G Longo, S Cinotti, E Filimberti, et al.
European Journal of Clinical Pharmacology
|
January 1, 1988
Multi-variate analysis of factors governing the pharmacokinetics of exogenous factor VIII in haemophiliacs
A Messori, G Longo, M Morfini, et al.
In Vivo (Athens, Greece)
|
January 6, 2007
Thalidomide plus monthly high-dose dexamethasone in chemorefractory myeloma. Results of a phase II clinical study
P Bernardeschi, G Giustarini, I Montenora, et al.
Leukemia
|
March 14, 2008
Fludarabine combination therapy for follicular lymphoma followed by acute myeloid leukemia: two further case records
P Bernardeschi, G Fiorentini, P Dentico, et al.
American Journal of Hematology
|
March 1, 1989
Evaluation of factor VIII pharmacokinetics in hemophilia-A subjects undergoing surgery and description of a nomogram for dosing calculations
G Longo, A Messori, M Morfini, et al.
Journal of Medical Virology
|
February 1, 1992
Low risk of transmission of the human immunodeficiency virus by a solvent-detergent-treated commercial factor VIII concentrate
T Di Paolantonio, G Mariani, A Ghirardini, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Minerva Chirurgica
|
November 1, 1996
[Cancerous colonic polyps]
R Manetti, M Biagini, G Giustarini
Journal of Experimental & Clinical Cancer Research : CR
|
June 14, 2006
Low-dose thalidomide plus monthly high-dose oral dexamethasone (Thali-Dexa): results, prognostic factors and side effects in eight patients previously treated with multiple myeloma
P Bemardeschi, P Dentico, S Rossi, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
June 14, 2006
Thyroid metastases from colon cancer case report in a long term survivor
S Rossi, G Fiorentini, G Porcu, et al.
Journal of Chemotherapy (Florence, Italy)
|
January 29, 2005
Chemoresistant myeloma: phase II clinical study with low-dose thalidomide plus high-dose dexamethasone
P Bernardeschi, P Dentico, S Rossi, et al.
European Journal of Haematology
|
November 1, 1987
Single-dose pharmacokinetics of factor IX evaluated by model-independent methods
G Longo, S Cinotti, E Filimberti, et al.
European Journal of Clinical Pharmacology
|
January 1, 1988
Multi-variate analysis of factors governing the pharmacokinetics of exogenous factor VIII in haemophiliacs
A Messori, G Longo, M Morfini, et al.
In Vivo (Athens, Greece)
|
January 6, 2007
Thalidomide plus monthly high-dose dexamethasone in chemorefractory myeloma. Results of a phase II clinical study
P Bernardeschi, G Giustarini, I Montenora, et al.
Leukemia
|
March 14, 2008
Fludarabine combination therapy for follicular lymphoma followed by acute myeloid leukemia: two further case records
P Bernardeschi, G Fiorentini, P Dentico, et al.
American Journal of Hematology
|
March 1, 1989
Evaluation of factor VIII pharmacokinetics in hemophilia-A subjects undergoing surgery and description of a nomogram for dosing calculations
G Longo, A Messori, M Morfini, et al.
Journal of Medical Virology
|
February 1, 1992
Low risk of transmission of the human immunodeficiency virus by a solvent-detergent-treated commercial factor VIII concentrate
T Di Paolantonio, G Mariani, A Ghirardini, et al.
Page
of 2